Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...
The proportion of patients with ACOS among individuals with existing COPD is unclear, as it depends very much on the applied defining criteria, but has been reported to be between 15 and 60%. 13–15 ...
Please provide your email address to receive an email when new articles are posted on . In a cohort of individuals with respiratory symptoms, 21% had undiagnosed COPD or asthma. Researchers found ...
Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...
The overlap between asthma and chronic obstructive pulmonary disease (COPD) is an important clinical phenomenon. However, the prevalence of asthma–COPD overlap syndrome (ACOS) is not known. Fifty-two ...
Background: Asthma and COPD can significantly affect patients and pose a substantial economic burden for both patients and managed-care plans. This study compares utilization outcomes in patients with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. COPD exacerbations went down by 51% in patients with ...
A high-pitched whistling sound when you breathe is the first tip-off that air is fighting to make its way into or out of your lungs. That sound is aptly named wheezing, and it is something that people ...
A study found that chronic obstructive pulmonary disease (COPD) and asthma were not risk factors for ICU admission or death as a result of SARS-CoV-2 infection. The study contradicts the widely ...
Chronic Obstructive Pulmonary Disease (COPD) is a long-term respiratory condition that is not entirely reversible and is characterized by restricted airflow. When we breathe, carbon dioxide is ...
Plus, hear from someone who took part in the trial THE first new treatment for asthma attacks in 50 years has been developed and could be “game-changing” for millions of people with the condition.